RxDoctor Payments Data

William Crawford, MD

Family Medicine · Havelock, NCNPI 1730117110

Payments from drug & device makers

$1,246in general payments, 2019–2025

Across 65 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$202
  • Novo Nordisk$164
  • AbbVie$162
  • Teleflex LLC$116
  • Bayer$115
  • Lilly USA, LLC$90
  • plus $397 from 13 others

What the payments were for

  • Food & beverage$1,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,246 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$239,718
Medicare patients
358
Services billed
14,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$85,938
OzempicSemaglutide48$81,775
JardianceEmpagliflozin80$68,585
MounjaroTirzepatide50$51,364
TrulicityDulaglutide30$35,288
XareltoRivaroxaban28$27,754
FarxigaDapagliflozin Propanediol28$24,550
RybelsusSemaglutide12$21,304
JanuviaSitagliptin Phosphate12$15,596
Breo ElliptaFluticasone/Vilanterol22$11,306
Tresiba Flextouch U-200Insulin Degludec13$7,981
SymbicortBudesonide/Formoterol Fumarate22$6,607
Lantus SolostarInsulin Glargine,hum.Rec.Anlog68$6,350
Gabapentin253$4,937
Omeprazole229$4,785

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$164$103,08060 claims
Lilly USA, LLCMounjaro, Trulicity$90$86,65280 claims
PfizerEliquis$55$85,93897 claims
Boehringer IngelheimJardiance$33$68,58580 claims
Johnson & JohnsonXarelto$13$27,75428 claims
GSKBreo Ellipta$17$11,30622 claims
AbbVieSynthroid$162$2,98242 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Havelock

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →